Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1
BMC Endocrine Disorders · 2024
DOI: 10.1186/s12902-024-01639-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Endocrine Disorders, 2024. Verfasst von Mohd Zahoor Ul Haq Shah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Endocrinology, Department of Bioscience, Barkatullah University, Madhya Predesh, Bhopal, 462026, India. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Disease Models, Animal, Anthraquinones, Insulin Resistance. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
This study aimed to explore the impact of Diacerein (DIC) on endocrine and cardio-metabolic changes in polycystic ovarian syndrome (PCOS) mouse model.
Methods
A total of 18 adult female mice (Parkes strain), aged 4–5 weeks, were randomly assigned to three groups, each comprising 6 animals, as follows: Group I (control), received normal diet and normal saline as vehicle for 51 days; Group II received Letrozole (LET; 6 mg/kg bw) for 21 days to induce PCOS; Group III received LET, followed by daily oral gavage administration of DIC (35 mg/kg bw) for 30 days.
Results
This study indicates that treatment with LET resulted in PCOS with characteristics such as polycystic ovaries, elevated testosterone, weight gain, visceral adiposity, high levels of insulin as well as fasting blood glucose in addition to insulin resistance, improper handling of ovarian lipids, atherogenic dyslipidemia, impaired Na + /K + -ATPase activity and serum, cardiac, and ovarian oxidative stress. Serum/ovarian adiponectin levels were lowered in LET-treated mice. In mice treated with LET, we also discovered a reduction in cardiac and serum paraoxonase 1 (PON1). Interestingly, DIC restored ovarian andcardio-metabolic abnormalities in LET-induced PCOS mice. DIC prevented the endocrine and cardio-metabolic changes brought on by letrozole-induced PCOS in mice.
Conclusion
The ameliorative effects of DIC on letrozole-induced PCOS with concurrent oxidative stress, abdominal fat deposition, cardiac and ovarian substrate mishandling, glucometabolic dysfunction, and adiponectin/PON1 activation support the idea that DIC perhaps, restore compromised endocrine and cardio-metabolic regulators in PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Endocrinology, Department of Bioscience, Barkatullah University, Madhya Predesh, Bhopal, 462026, India.
- Department of obstetrics and Gynecology, Centre for Reproductive Medicine, the Fourth Affiliated Hospital of school of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, 322000, China.
- Molecular Biology Laboratory, Faculty of Veterinary Sciences and Animal Husbandary, SKAUST-K, Srinagar, India.
- Department of Physiology, College of Medicine and Health Sciences, Cardio/Endo-metabolic and Microbiome Research Unit, Afe Babalola University, Ado-Ekiti, 360101, Nigeria. olaniyisk@abuad.edu.ng.
Zitieren
APA
Shah, M. Z. U. H., Shrivastava, V. K., Muzamil, S., & Olaniyi, K. S. (2024). Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01639-9
Vancouver
Shah MZUH, Shrivastava VK, Muzamil S, Olaniyi KS. Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1. BMC Endocrine Disorders. 2024. doi:10.1186/s12902-024-01639-9
BibTeX
@article{Shah2024,
author = {Shah, Mohd Zahoor Ul Haq and Shrivastava, Vinoy Kumar and Muzamil, Showkeen and Olaniyi, Kehinde S},
title = {Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1},
journal = {BMC Endocrine Disorders},
year = {2024},
doi = {10.1186/s12902-024-01639-9}
}
EUVIMED